All Pharma News
US FDA grants approval for Radius’ Tymlos for osteoporosis in men

US FDA grants approval for Radius’ Tymlos for osteoporosis in men
PHARMACEUTICAL-TECHNOLOGY
22 Dec 2022
Share Share
EU Moment of Truth For Abaloparatide & Advanced Therapy Tab-Cel

EU Moment of Truth For Abaloparatide & Advanced Therapy Tab-Cel
PHARMAINTELLIGENCE
11 Oct 2022
Share Share
Gurnet Point & Patient Square Complete Their Acquisition of Radius Health

Gurnet Point & Patient Square Complete Their Acquisition of Radius Health
GLOBENEWSWIRE
15 Aug 2022
Share Share
Menarini Group’s Elacestrant Granted Priority Review by the U.S. FDA

Menarini Group’s Elacestrant Granted Priority Review by the U.S. FDA
BUSINESSWIRE
11 Aug 2022
Share Share
Radius Announces First Patient Randomized in RAD011 Pivotal Trial for PWS

Radius Announces First Patient Randomized in RAD011 Pivotal Trial for PWS
GLOBENEWSWIRE
07 Jul 2022
Share Share
Radius Health Publishes Investor Presentation Outlining Company`s Progress

Radius Health Publishes Investor Presentation Outlining Company`s Progress
GLOBENEWSWIRE
07 Jul 2022
Share Share
2 investment firms buy Radius, bone drug Tymlos for $890M

2 investment firms buy Radius, bone drug Tymlos for $890M
Kevin Dunleavy FIERCEPHARMA
24 Jun 2022
Share Share
Menarini Group and Radius Health Submit NDA to the U.S. FDA for Elacestrant

Menarini Group and Radius Health Submit NDA to the U.S. FDA for Elacestrant
PRNEWSWIRE
22 Jun 2022
Share Share
Radius Health Expands Non-US Market Footprint for TYMLOS

Radius Health Expands Non-US Market Footprint for TYMLOS
GLOBENEWSWIRE
08 Jun 2022
Share Share
Activist investors attempt to change the course at Radius Health

Activist investors attempt to change the course at Radius Health
Max Gelman ENDPTS
07 Jun 2022
Share Share